ICG
VRTX icon

InterOcean Capital Group’s Vertex Pharmaceuticals VRTX Stock Holding History

InterOcean Capital Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$731K Buy
1,749
+377
+27% +$159K 0.02% 254
2023
Q4 		$558K Buy
+1,372
New +$507K 0.02% 270

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

InterOcean Capital Group's VRTX Position: Q1 2024 in Review

InterOcean Capital Group increased its Vertex Pharmaceuticals (VRTX) stake by 27% in Q1 2024, buying an estimated $159K and bringing the position to 1,749 shares worth $731K. The position accounts for 0.02% of the portfolio, ranked #254.

InterOcean Capital Group first reported a position in VRTX in Q4 2023 and has held it in 2 quarters since. 1,495 funds tracked by Wall St. Rank hold VRTX as of Q1 2024.

  • InterOcean Capital Group held 1,749 shares of Vertex Pharmaceuticals worth $731K as of Q1 2024.
  • InterOcean Capital Group bought 377 Vertex Pharmaceuticals shares in Q1 2024, an estimated $159K.
  • Vertex Pharmaceuticals made up 0.02% of InterOcean Capital Group's portfolio in Q1 2024, its #254 holding.
  • InterOcean Capital Group first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 2 quarters since.
  • 1,495 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.